» Articles » PMID: 36891782

Fibrin Gel Enhanced Trilayer Structure in Cell-cultured Constructs

Overview
Publisher Wiley
Specialty Biochemistry
Date 2023 Mar 9
PMID 36891782
Authors
Affiliations
Soon will be listed here.
Abstract

Efficient cell seeding and subsequent support from a substrate ensure optimal cell growth and neotissue development during tissue engineering, including heart valve tissue engineering. Fibrin gel as a cell carrier may provide high cell seeding efficiency and adhesion property, improved cellular interaction, and structural support to enhance cellular growth in trilayer polycaprolactone (PCL) substrates that mimic the structure of native heart valve leaflets. This cell carrier gel coupled with a trilayer PCL substrate may enable the production of native-like cell-cultured leaflet constructs suitable for heart valve tissue engineering. In this study, we seeded valvular interstitial cells onto trilayer PCL substrates with fibrin gel as a cell carrier and cultured them for 1 month in vitro to determine if this gel can improve cell proliferation and production of extracellular matrix within the trilayer cell-cultured constructs. We observed that the fibrin gel enhanced cellular proliferation, their vimentin expression, and collagen and glycosaminoglycan production, leading to improved structure and mechanical properties of the developing PCL cell-cultured constructs. Fibrin gel as a cell carrier significantly improved the orientations of the cells and their produced tissue materials within trilayer PCL substrates that mimic the structure of native heart valve leaflets and, thus, may be highly beneficial for developing functional tissue-engineered leaflet constructs.

Citing Articles

Non-immune factors cause prolonged myofibroblast phenotype in implanted synthetic heart valve scaffolds.

Snyder Y, Mann F, Middleton J, Murashita T, Carney J, Bianco R Appl Mater Today. 2024; 39.

PMID: 39131741 PMC: 11308761. DOI: 10.1016/j.apmt.2024.102323.


Strategies for Development of Synthetic Heart Valve Tissue Engineering Scaffolds.

Snyder Y, Jana S Prog Mater Sci. 2023; 139.

PMID: 37981978 PMC: 10655624. DOI: 10.1016/j.pmatsci.2023.101173.

References
1.
Brugmans M, Sntjens S, Cox M, Nandakumar A, Bosman A, Mes T . Hydrolytic and oxidative degradation of electrospun supramolecular biomaterials: In vitro degradation pathways. Acta Biomater. 2015; 27:21-31. DOI: 10.1016/j.actbio.2015.08.034. View

2.
Hjortnaes J, Shapero K, Goettsch C, Hutcheson J, Keegan J, Kluin J . Valvular interstitial cells suppress calcification of valvular endothelial cells. Atherosclerosis. 2015; 242(1):251-260. PMC: 4546848. DOI: 10.1016/j.atherosclerosis.2015.07.008. View

3.
Taghizadeh B, Ghavami L, Derakhshankhah H, Zangene E, Razmi M, Jaymand M . Biomaterials in Valvular Heart Diseases. Front Bioeng Biotechnol. 2021; 8:529244. PMC: 7793990. DOI: 10.3389/fbioe.2020.529244. View

4.
Chen W, Zhou H, Weir M, Bao C, Xu H . Umbilical cord stem cells released from alginate-fibrin microbeads inside macroporous and biofunctionalized calcium phosphate cement for bone regeneration. Acta Biomater. 2012; 8(6):2297-306. PMC: 3360975. DOI: 10.1016/j.actbio.2012.02.021. View

5.
Nam J, Huang Y, Agarwal S, Lannutti J . Improved cellular infiltration in electrospun fiber via engineered porosity. Tissue Eng. 2007; 13(9):2249-57. PMC: 4948987. DOI: 10.1089/ten.2006.0306. View